Proff C, Kölling R
Institut für Mikrobiologie, Heinrich-Heine-Universität Düsseldorf, Germany.
Mol Gen Genet. 2001 Feb;264(6):883-93. doi: 10.1007/s004380000378.
The yeast a-factor transporter Ste6 is a member of the ABC transporter family and is closely related to human MDR1. We constructed a set of 26 Ste6 mutants using a random mutagenesis approach. Cell fractionation experiments demonstrated that most of the mutants, with the notable exception of those with alterations in TM1, are transported to the plasma membrane, the presumptive site of action of Ste6. Trafficking, therefore, does not seem to be affected in most of the mutants. To identify regions in Ste6 that interact with the ABC transporter "signature motif" (LSGGQ) we screened for intragenic revertants of the LSGGQ mutant M68 (S507N). Suppressor mutations were identified in TM12 and upstream of TM6. Surprisingly, these mutations also suppressed the Walker A mutation G397D, which should be defective in ATP-binding and hydrolysis at NBD1. Photoaffinity labeling experiments with 8-azido-[alpha-32P]ATP showed that ATP binding at NBD2 is reduced by the suppressor mutation in TM12. The experiments further suggest that the two NBDs of Ste6 are not equivalent and affect each other's ability to bind and hydrolyze ATP.
酵母α-因子转运蛋白Ste6是ABC转运蛋白家族的成员,与人类多药耐药蛋白1(MDR1)密切相关。我们采用随机诱变方法构建了一组26个Ste6突变体。细胞分级分离实验表明,除了跨膜区1(TM1)发生改变的那些突变体之外,大多数突变体都被转运到质膜,这是Ste6可能的作用位点。因此,在大多数突变体中,转运似乎未受影响。为了确定Ste6中与ABC转运蛋白“特征基序”(LSGGQ)相互作用的区域,我们筛选了LSGGQ突变体M68(S507N)的基因内回复突变体。在跨膜区12(TM12)和跨膜区6(TM6)上游鉴定到了抑制突变。令人惊讶的是,这些突变也抑制了沃克A突变G397D,该突变在核苷结合域1(NBD1)的ATP结合和水解方面应该存在缺陷。用8-叠氮基-[α-32P]ATP进行的光亲和标记实验表明,TM12中的抑制突变降低了NBD2处的ATP结合。这些实验进一步表明,Ste6 的两个核苷结合域并不等同,且会相互影响彼此结合和水解ATP的能力。